Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 98,094 | 159,519 | 137,545 | 91,386 | 63,301 |
| Depreciation Amortization | 60,050 | 58,999 | 49,434 | 25,235 | 23,486 |
| Income taxes - deferred | 28,660 | -17,872 | -12,578 | -16,445 | 2,388 |
| Accounts receivable | -6,367 | -21,671 | -26,086 | -10,132 | -14,921 |
| Other Working Capital | -65,971 | -14,547 | -24,209 | -32,177 | -1,951 |
| Other Operating Activity | 41,649 | 48,958 | 59,397 | 31,314 | 25,691 |
| Operating Cash Flow | $156,115 | $213,386 | $183,503 | $89,181 | $97,994 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -28,839 | 49,230 | -105,934 | -7,792 | 1,396 |
| PPE Investments | -34,882 | -41,041 | -38,166 | -23,613 | -27,456 |
| Net Acquisitions | N/A | -129,000 | -506,406 | N/A | N/A |
| Purchase Sale Intangibles | -2,250 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -6,611 | -4,119 | 1,390 | -1,372 | -2,612 |
| Investing Cash Flow | $-70,332 | $-124,930 | $-649,116 | $-32,777 | $-28,672 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,216 | 18,433 | 845,000 | 0 | 70,000 |
| Debt Repayment | -223 | -8,263 | -318,658 | -1,781 | -37,901 |
| Common Stock Issued | 2,855 | -4,849 | 10,974 | 15,658 | 15,925 |
| Common Stock Repurchased | -75,586 | -85,458 | -58,144 | -39,909 | -28,873 |
| Other Financing Activity | -687 | -816 | -25,079 | -407 | -56,169 |
| Financing Cash Flow | $-67,425 | $-80,953 | $454,093 | $-26,439 | $-37,018 |
| Exchange Rate Effect | 210 | -190 | -282 | -220 | -223 |
| Beginning Cash Position | 151,844 | 144,531 | 156,333 | 126,588 | 94,507 |
| End Cash Position | 170,412 | 151,844 | 144,531 | 156,333 | 126,588 |
| Net Cash Flow | $18,568 | $7,313 | $-11,802 | $29,745 | $32,081 |
| Free Cash Flow | |||||
| Operating Cash Flow | 156,115 | 213,386 | 183,503 | 89,181 | 97,994 |
| Capital Expenditure | -34,882 | -41,041 | -38,166 | -24,034 | -27,456 |
| Free Cash Flow | 121,233 | 172,345 | 145,337 | 65,147 | 70,538 |